Ep22 - Science News Recap October

Posted on Tuesday, Oct 27, 2020
Starting this month, we will be highlighting the main news in science for the month. This month, we highlighted three main stories - (1) Nobel Prize in Chemistry for CRISPR (2) Editorial in New England Journal of medicine “Dying in a Leadership Vacuum” (3) What’s new in Remdesivir news? Contradicting evidence publications and FDA approval..

Show Notes


  1. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. science, 337(6096), 816-821. https://science.sciencemag.org/content/337/6096/816.abstract

  2. Science article - https://www.sciencemag.org/news/2017/02/how-battle-lines-over-crispr-were-drawn

  3. Editors. “Dying in a Leadership Vacuum.” (2020): 1479-1480.https://www.nejm.org/doi/full/10.1056/NEJMe2029812

  4. Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., Lopez de Castilla, D., Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W. R., Touloumi, G., … ACTT-1 Study Group Members (2020). Remdesivir for the Treatment of Covid-19 - Final Report. The New England journal of medicine, NEJMoa2007764. Advance online publication. https://www.nejm.org/doi/full/10.1056/NEJMoa2007764


Arshi Arora

Arshi Arora

Arshi Arora is a Research Biostatistician at Memorial Sloan Kettering Cancer Center. She holds a double Masters of Science degree in Computational Biology and Biostatistics from Carnegie Mellon and Columbia University respectively. Her interests lie in creating elegant solutions to biological and clinical questions via simple yet compelling statistical models. She is a minimalist and follows an intense recycling waste regimen.

Sabah Kadri, PhD

Sabah Kadri, PhD

Dr. Sabah Kadri has a background in Computer Engineering with a PhD in Computational Biology from Carnegie Mellon University. Dr. Kadri leads a team of bioinformaticians and scientists to design, develop and implement cloud-based computational infrastructure and containerized bioinformatics software in clinical diagnostic services for germline and somatic next generation sequencing (NGS) testing. She has experience building clinical diagnostics pipelines and systems for adult and pediatric diseases and continues to work on informatics solutions and research questions for translational ‘omics’ and biomedical research to promote personalized medicine.